Terminated PHASE3 INTERVENTIONAL NCT00387114

Effect of an Anti-Oxidant Treatment on Resistin Serum Levels.A Randomized Study

Sponsor: University of Turin, Italy

Conditions Metabolic Diseases Oxidative Stress

Interventions Vitamin C

Updated 4 times since 2017 Last updated: Oct 10, 2006 Started: Jun 30, 2005 Completion: Nov 30, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from University of Turin, Italy

See all terminations from University of Turin, Italy

Other Metabolic Diseases trials with similar outcome

Browse all Metabolic Diseases trials

This PHASE3 trial investigates Metabolic Diseases and Oxidative Stress and is currently terminated or withdrawn. University of Turin, Italy leads this study, which shows 4 recorded versions since 2005 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE3
Jan 2017 — Jan 2021 [monthly]

Terminated PHASE3

First recorded

Jun 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Turin, Italy

Data source: University of Turin, Italy

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Turin, Italy